Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new ...

In 2005, Sandoz became the world leader in generic pharmaceuticals after acquiring Germany's Hexal AG and US-based Eon Labs. The same year, Novartis acquired the North American over-the-counter ...